CTRI/2022/02/040442尚未招募3 期
Comparative study between weekly dose of 50mg Mifepristone and daily dose of 25 mg Mifepristone in medical management of UTERINE FIBROID
Dr Subhasri S0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Women of age group 30-45
- •Women with symptomatic fibroid
- •Fibroid size 3-5cm
- •Without endometrial hyperplasia
排除标准
- •Uterine size more than 12weeks
- •Associated cervical or tubal lesions
- •Fibroid with severe anemia
- •Hepatic and renal dysfunction
- •Endometrial hyperplasia
研究者
相似试验
已完成
不适用
A comparative pharmacokinetic study of oral mifepristone and vaginal misoprostol in pregnant womePregnancyPregnancy and ChildbirthISRCTN35300716World Health Organization (WHO) (Switzerland)60
招募中
2 期
To compare Oral Mifepristone with Foley catheter for softening of cervix in women planned for delivery at or after 39 weeks of pregnancyCTRI/2021/07/034943JIPMER INTRAMURA
已完成
不适用
Study comparing two methods of abortion in second trimester using misoprostol or ethacridine lactate after priming with mifepristoneCTRI/2018/01/011157Project in the Department of Obstetrics and Gynecology120
进行中（未招募）
不适用
Comparison between two different dosages of remifentanil administered by a patient controlled tecnique (PCSA) for diagnostic and andoscopich procedures. - NDEUCTR2009-010383-42-ITOSPEDALE S. RAFFAELE
已完成
不适用
Misoprostol for induction of laborCTRI/2012/07/002785Sikkim Manipal Institute of Medical Sciences250